import React from 'react';

export function C31ReferencesLegalInfo(props){
	const {
    size = "L(LHN)"
  } = props;
  return (
      <>
  {(size == "L(LHN)") && <>
    <div className="c31ReferencesLegalInfo gap-16 absolute flex-col w-[1164px] items-start bg-white opacity-100 pt-16 pb-24 px-16 left-4 top-4 flex">
      <div className="sectionHeading gap-[-1px] flex-col w-[1100px] items-start opacity-100 p-0 flex">
        <div className="frame1199 gap-2 flex-row items-start border opacity-100 px-[9px] py-[5px] border-black flex">
          <span className="sectionHeading font-['Volta_Modern_Display'] text-[25px] font-medium text-black text-left tracking-[0px]">References</span>
        </div>
        <div className="1pxDivider w-full h-px relative overflow-hidden bg-[#212121] opacity-100 p-0" />
      </div>
      <div className="frame482815 gap-6 flex-row items-start w-full opacity-100 p-0 flex">
        <div className="frame482779 gap-2 flex-col items-start flex-1 min-w-0 opacity-100 p-0 flex">
          <div className="frame482807 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2997 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-[#0460a9] opacity-100 p-0" />
              <div className="interactiveIcons w-3 h-3 absolute opacity-100 p-0 left-0.5 top-0.5">
                <div className="boundingBox absolute w-3 h-3 bg-[#d9d9d9] opacity-100 p-0 inset-[0%]" />
                <svg width={10} height={10} viewBox="0 0 10 10" fill="none" xmlns="http://www.w3.org/2000/svg">
                  <path d="M4.4375 9.5V2.65156L1.2875 5.80156L0.5 5L5 0.5L9.5 5L8.7125 5.80156L5.5625 2.65156V9.5H4.4375Z" fill="white" />
                </svg>
              </div>
            </div>
            <span className="virgoliniIEtAlEurJNuclMedMolImaging201845347195 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[482px] flex-1 min-w-0">Virgolini I, et al. Eur J Nucl Med Mol Imaging. 2018;45(3):471–95.</span>
          </div>
          <div className="frame482808 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">2</span>
            </div>
            <span className="lUTATHERALutetium177LuOxodotreotideSmPCAvailableFromHttpswwwemaeuropaeuendocumentsproductInformationlutatheraEparProductInformationenpdfAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[482px] flex-1 min-w-0">LUTATHERA® (lutetium [177Lu] oxodotreotide) SmPC. Available from: <span className="text-[#0460a9] underline">https://www.ema.europa.eu/en/documents/product-information/lutathera-epar-product-information_en.pdf. Accessed May 2021.</span></span>
          </div>
          <div className="component34 w-6 h-[26px] absolute opacity-100 p-0 left-1 top-2">
            <div className="rectangle4536 absolute w-[17.48px] h-[4.26px] bg-[#d9d9d9] opacity-100 p-0 left-[20%] right-[7.18%] top-[64.62%] bottom-[19%]" />
            <div className="rectangle4533 absolute w-[3.07px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[7.19%] right-[80%] top-[42.69%] bottom-[42.4%]" />
            <div className="rectangle4534 absolute w-[20.25px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[13.44%] right-[2.19%] top-[49.12%] bottom-[35.97%]" />
            <div className="rectangle4535 absolute w-[19.13px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[14.69%] right-[5.63%] top-[53.8%] bottom-[31.29%]" />
            <div className="rectangle4537 absolute w-[12.52px] h-[1.6px] bg-[#d9d9d9] opacity-100 p-0 left-[33.44%] right-[14.38%] top-[80.99%] bottom-[12.87%]" />
            <div className="rectangle4538 absolute w-[10.95px] h-[2.81px] bg-[#d9d9d9] opacity-100 p-0 left-[37.81%] right-[16.57%] top-[85.09%] bottom-[4.09%]" />
            <div className="rectangle4539 absolute w-[3.9px] h-[12.92px] bg-[#d9d9d9] opacity-100 p-0 left-[32.81%] right-[50.94%] top-[6.14%] bottom-[44.15%]" />
            <div className="rectangle4540 absolute w-[8.77px] h-[5.63px] bg-[#d9d9d9] opacity-100 p-0 left-[43.44%] right-[20.01%] top-[30.99%] bottom-[47.37%]" />
            <div className="rectangle4541 absolute w-[5.25px] h-[3.95px] bg-[#d9d9d9] opacity-100 p-0 left-[71.56%] right-[6.56%] top-[37.43%] bottom-[47.37%]" />
            <img src="/images/image202.png" onerror="this.src='http://svgur.com/i/x4x.svg'" className="image202 absolute h-[26px] w-6 opacity-100 object-cover p-0 inset-[0%]" />
          </div>
          <div className="frame482809 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">3</span>
            </div>
            <div className="group2999 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">A</span>
            </div>
            <div className="group3000 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">B</span>
            </div>
            <span className="httpswwwwhointmedicinesareasprioritymedicinesCh612Osteopdf font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[434px] flex-1 min-w-0">https://www.who.int/medicines/areas/priority_medicines/Ch6_12Osteo.pdf</span>
          </div>
          <div className="frame482810 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2999 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-[#023054] opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-white text-center tracking-[0px] w-4 h-4">4</span>
            </div>
            <span ItemNumber="undefined" className="sNMMI2018PeptideReceptorRadionuclideTherapyPRRTFactSheetAvailableFromHttpswwwsnmmiorgAboutSNMMIContentaspxAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[482px] flex-1 min-w-0">SNMMI (2018). Peptide Receptor Radionuclide Therapy (PRRT) Fact Sheet. Available from:<span className="text-[#0460a9] underline"> https://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=29883. Accessed May 2021.</span></span>
          </div>
          <div className="frame482811 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">5</span>
            </div>
            <span className="trattnigSScottiCLaurentDJurasVHackerSColeBPasaLLehovecRSzomolanyiPRaithelESaxerFPraestgaardJLaGambaFJimenezJLRamosDSRoubenoffRSchiekerM2021POS0277ANABOLICEFFECTOFLNA043ANOVELDISEASEMODIFYINGOSTEOARTHRITISDRUGCANDIDATERESULTSFROMANIMAGINGBASEDPROOFOFCONCEPTTRIALINPATIENTSWITHFOCALARTICULARCARTILAGELESIONSBMJJournalsViewed4June2021Httpsardbmjcomcontent80Suppl13632 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[482px] flex-1 min-w-0">Trattnig, S, Scotti, C, Laurent, D, Juras, V, Hacker, S, Cole, B, Pasa, L, Lehovec, R, Szomolanyi, P, Raithel, E, Saxer, F, Praestgaard, J, La Gamba, F, Jiménez, J L, Ramos, D S, Roubenoff, R, Schieker M 2021, POS0277 ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS, BMJ Journals, viewed 4 June 2021, <https: 80 ard.bmj.com content Suppl_1 363.2>.</https:></span>
          </div>
        </div>
        <div className="frame482780 gap-2 flex-col items-start flex-1 min-w-0 opacity-100 p-0 flex">
          <div className="frame482807 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">6</span>
            </div>
            <span className="virgoliniIEtAlEurJNuclMedMolImaging201845347195 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[482px] flex-1 min-w-0">Virgolini I, et al. Eur J Nucl Med Mol Imaging. 2018;45(3):471–95.</span>
          </div>
          <div className="frame482808 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">7</span>
            </div>
            <span className="lUTATHERALutetium177LuOxodotreotideSmPCAvailableFromHttpswwwemaeuropaeuendocumentsproductInformationlutatheraEparProductInformationenpdfAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[482px] flex-1 min-w-0">LUTATHERA® (lutetium [177Lu] oxodotreotide) SmPC. Available from: <span className="text-[#0460a9] underline">https://www.ema.europa.eu/en/documents/product-information/lutathera-epar-product-information_en.pdf. Accessed May 2021.</span></span>
          </div>
          <div className="frame482809 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">8</span>
            </div>
            <span className="httpswwwwhointmedicinesareasprioritymedicinesCh612Osteopdf font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[482px] flex-1 min-w-0">https://www.who.int/medicines/areas/priority_medicines/Ch6_12Osteo.pdf</span>
          </div>
          <div className="frame482810 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">9</span>
            </div>
            <span ItemNumber="undefined" className="sNMMI2018PeptideReceptorRadionuclideTherapyPRRTFactSheetAvailableFromHttpswwwsnmmiorgAboutSNMMIContentaspxAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[482px] flex-1 min-w-0">SNMMI (2018). Peptide Receptor Radionuclide Therapy (PRRT) Fact Sheet. Available from:<span className="text-[#0460a9] underline"> https://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=29883. Accessed May 2021.</span></span>
          </div>
          <div className="frame482811 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">10</span>
            </div>
            <span className="trattnigSScottiCLaurentDJurasVHackerSColeBPasaLLehovecRSzomolanyiPRaithelESaxerFPraestgaardJLaGambaFJimenezJLRamosDSRoubenoffRSchiekerM2021POS0277ANABOLICEFFECTOFLNA043ANOVELDISEASEMODIFYINGOSTEOARTHRITISDRUGCANDIDATERESULTSFROMANIMAGINGBASEDPROOFOFCONCEPTTRIALINPATIENTSWITHFOCALARTICULARCARTILAGELESIONSBMJJournalsViewed4June2021Httpsardbmjcomcontent80Suppl13632 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[482px] flex-1 min-w-0">Trattnig, S, Scotti, C, Laurent, D, Juras, V, Hacker, S, Cole, B, Pasa, L, Lehovec, R, Szomolanyi, P, Raithel, E, Saxer, F, Praestgaard, J, La Gamba, F, Jiménez, J L, Ramos, D S, Roubenoff, R, Schieker M 2021, POS0277 ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS, BMJ Journals, viewed 4 June 2021, <https: 80 ard.bmj.com content Suppl_1 363.2>.</https:></span>
          </div>
        </div>
      </div>
    </div>
  </>}
  {(size == "M") && <>
    <div className="c31ReferencesLegalInfo gap-10 absolute flex-col w-[768px] items-start bg-white opacity-100 pt-10 pb-16 px-8 left-[3083px] top-4 flex">
      <div className="sectionHeading gap-[-1px] flex-col w-[736px] items-start opacity-100 p-0 flex">
        <div className="frame1199 gap-2 flex-row items-start border opacity-100 px-[9px] py-[5px] border-black flex">
          <span className="sectionHeading font-['Volta_Modern_Display'] text-[17px] font-medium text-black text-left tracking-[0px]">References</span>
        </div>
        <div className="1pxDivider w-full h-px relative overflow-hidden bg-[#212121] opacity-100 p-0" />
      </div>
      <div className="frame482815 gap-6 flex-row items-start w-full opacity-100 p-0 flex">
        <div className="frame482781 gap-2 flex-col items-start flex-1 min-w-0 opacity-100 p-0 flex">
          <div className="frame482807 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2997 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-[#0460a9] opacity-100 p-0" />
              <div className="interactiveIcons w-3 h-3 absolute opacity-100 p-0 left-0.5 top-0.5">
                <div className="boundingBox absolute w-3 h-3 bg-[#d9d9d9] opacity-100 p-0 inset-[0%]" />
                <svg width={10} height={10} viewBox="0 0 10 10" fill="none" xmlns="http://www.w3.org/2000/svg">
                  <path d="M4.4375 9.5V2.65156L1.2875 5.80156L0.5 5L5 0.5L9.5 5L8.7125 5.80156L5.5625 2.65156V9.5H4.4375Z" fill="white" />
                </svg>
              </div>
            </div>
            <span className="virgoliniIEtAlEurJNuclMedMolImaging201845347195 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[316px] flex-1 min-w-0">Virgolini I, et al. Eur J Nucl Med Mol Imaging. 2018;45(3):471–95.</span>
          </div>
          <div className="frame482808 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">2</span>
            </div>
            <span className="lUTATHERALutetium177LuOxodotreotideSmPCAvailableFromHttpswwwemaeuropaeuendocumentsproductInformationlutatheraEparProductInformationenpdfAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[316px] flex-1 min-w-0">LUTATHERA® (lutetium [177Lu] oxodotreotide) SmPC. Available from: <span className="text-[#0460a9] underline">https://www.ema.europa.eu/en/documents/product-information/lutathera-epar-product-information_en.pdf. Accessed May 2021.</span></span>
          </div>
          <div className="component34 w-6 h-[26px] absolute opacity-100 p-0 left-1 top-2">
            <div className="rectangle4536 absolute w-[17.48px] h-[4.26px] bg-[#d9d9d9] opacity-100 p-0 left-[20%] right-[7.18%] top-[64.62%] bottom-[19%]" />
            <div className="rectangle4533 absolute w-[3.07px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[7.19%] right-[80%] top-[42.69%] bottom-[42.4%]" />
            <div className="rectangle4534 absolute w-[20.25px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[13.44%] right-[2.19%] top-[49.12%] bottom-[35.97%]" />
            <div className="rectangle4535 absolute w-[19.13px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[14.69%] right-[5.63%] top-[53.8%] bottom-[31.29%]" />
            <div className="rectangle4537 absolute w-[12.52px] h-[1.6px] bg-[#d9d9d9] opacity-100 p-0 left-[33.44%] right-[14.38%] top-[80.99%] bottom-[12.87%]" />
            <div className="rectangle4538 absolute w-[10.95px] h-[2.81px] bg-[#d9d9d9] opacity-100 p-0 left-[37.81%] right-[16.57%] top-[85.09%] bottom-[4.09%]" />
            <div className="rectangle4539 absolute w-[3.9px] h-[12.92px] bg-[#d9d9d9] opacity-100 p-0 left-[32.81%] right-[50.94%] top-[6.14%] bottom-[44.15%]" />
            <div className="rectangle4540 absolute w-[8.77px] h-[5.63px] bg-[#d9d9d9] opacity-100 p-0 left-[43.44%] right-[20.01%] top-[30.99%] bottom-[47.37%]" />
            <div className="rectangle4541 absolute w-[5.25px] h-[3.95px] bg-[#d9d9d9] opacity-100 p-0 left-[71.56%] right-[6.56%] top-[37.43%] bottom-[47.37%]" />
            <img src="/images/image202.png" onerror="this.src='http://svgur.com/i/x4x.svg'" className="image202 absolute h-[26px] w-6 opacity-100 object-cover p-0 inset-[0%]" />
          </div>
          <div className="frame482809 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">3</span>
            </div>
            <span className="httpswwwwhointmedicinesareasprioritymedicinesCh612Osteopdf font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[316px] flex-1 min-w-0">https://www.who.int/medicines/areas/priority_medicines/Ch6_12Osteo.pdf</span>
          </div>
          <div className="frame482810 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2999 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-[#023054] opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-white text-center tracking-[0px] w-4 h-4">4</span>
            </div>
            <span ItemNumber="undefined" className="sNMMI2018PeptideReceptorRadionuclideTherapyPRRTFactSheetAvailableFromHttpswwwsnmmiorgAboutSNMMIContentaspxAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[316px] flex-1 min-w-0">SNMMI (2018). Peptide Receptor Radionuclide Therapy (PRRT) Fact Sheet. Available from:<span className="text-[#0460a9] underline"> https://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=29883. Accessed May 2021.</span></span>
          </div>
          <div className="frame482811 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">5</span>
            </div>
            <span className="trattnigSScottiCLaurentDJurasVHackerSColeBPasaLLehovecRSzomolanyiPRaithelESaxerFPraestgaardJLaGambaFJimenezJLRamosDSRoubenoffRSchiekerM2021POS0277ANABOLICEFFECTOFLNA043ANOVELDISEASEMODIFYINGOSTEOARTHRITISDRUGCANDIDATERESULTSFROMANIMAGINGBASEDPROOFOFCONCEPTTRIALINPATIENTSWITHFOCALARTICULARCARTILAGELESIONSBMJJournalsViewed4June2021Httpsardbmjcomcontent80Suppl13632 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[316px] flex-1 min-w-0">Trattnig, S, Scotti, C, Laurent, D, Juras, V, Hacker, S, Cole, B, Pasa, L, Lehovec, R, Szomolanyi, P, Raithel, E, Saxer, F, Praestgaard, J, La Gamba, F, Jiménez, J L, Ramos, D S, Roubenoff, R, Schieker M 2021, POS0277 ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS, BMJ Journals, viewed 4 June 2021, <https: 80 ard.bmj.com content Suppl_1 363.2>.</https:></span>
          </div>
        </div>
        <div className="frame482782 gap-2 flex-col items-start flex-1 min-w-0 opacity-100 p-0 flex">
          <div className="frame482807 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">6</span>
            </div>
            <span className="virgoliniIEtAlEurJNuclMedMolImaging201845347195 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[316px] flex-1 min-w-0">Virgolini I, et al. Eur J Nucl Med Mol Imaging. 2018;45(3):471–95.</span>
          </div>
          <div className="frame482808 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">7</span>
            </div>
            <span className="lUTATHERALutetium177LuOxodotreotideSmPCAvailableFromHttpswwwemaeuropaeuendocumentsproductInformationlutatheraEparProductInformationenpdfAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[316px] flex-1 min-w-0">LUTATHERA® (lutetium [177Lu] oxodotreotide) SmPC. Available from: <span className="text-[#0460a9] underline">https://www.ema.europa.eu/en/documents/product-information/lutathera-epar-product-information_en.pdf. Accessed May 2021.</span></span>
          </div>
          <div className="frame482809 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">8</span>
            </div>
            <span className="httpswwwwhointmedicinesareasprioritymedicinesCh612Osteopdf font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[316px] flex-1 min-w-0">https://www.who.int/medicines/areas/priority_medicines/Ch6_12Osteo.pdf</span>
          </div>
          <div className="frame482810 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">9</span>
            </div>
            <span ItemNumber="undefined" className="sNMMI2018PeptideReceptorRadionuclideTherapyPRRTFactSheetAvailableFromHttpswwwsnmmiorgAboutSNMMIContentaspxAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[316px] flex-1 min-w-0">SNMMI (2018). Peptide Receptor Radionuclide Therapy (PRRT) Fact Sheet. Available from:<span className="text-[#0460a9] underline"> https://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=29883. Accessed May 2021.</span></span>
          </div>
          <div className="frame482811 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">10</span>
            </div>
            <span className="trattnigSScottiCLaurentDJurasVHackerSColeBPasaLLehovecRSzomolanyiPRaithelESaxerFPraestgaardJLaGambaFJimenezJLRamosDSRoubenoffRSchiekerM2021POS0277ANABOLICEFFECTOFLNA043ANOVELDISEASEMODIFYINGOSTEOARTHRITISDRUGCANDIDATERESULTSFROMANIMAGINGBASEDPROOFOFCONCEPTTRIALINPATIENTSWITHFOCALARTICULARCARTILAGELESIONSBMJJournalsViewed4June2021Httpsardbmjcomcontent80Suppl13632 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[316px] flex-1 min-w-0">Trattnig, S, Scotti, C, Laurent, D, Juras, V, Hacker, S, Cole, B, Pasa, L, Lehovec, R, Szomolanyi, P, Raithel, E, Saxer, F, Praestgaard, J, La Gamba, F, Jiménez, J L, Ramos, D S, Roubenoff, R, Schieker M 2021, POS0277 ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS, BMJ Journals, viewed 4 June 2021, <https: 80 ard.bmj.com content Suppl_1 363.2>.</https:></span>
          </div>
        </div>
      </div>
    </div>
  </>}
  {(size == "L") && <>
    <div className="c31ReferencesLegalInfo gap-16 absolute flex-col w-[1440px] items-start bg-white opacity-100 pt-16 pb-24 px-12 left-[1390px] top-4 flex">
      <div className="sectionHeading gap-[-1px] flex-col w-[1392px] items-start opacity-100 p-0 flex">
        <div className="frame1199 gap-2 flex-row items-start border opacity-100 px-[9px] py-[5px] border-black flex">
          <span className="sectionHeading font-['Volta_Modern_Display'] text-[25px] font-medium text-black text-left tracking-[0px]">References</span>
        </div>
        <div className="1pxDivider w-full h-px relative overflow-hidden bg-[#212121] opacity-100 p-0" />
      </div>
      <div className="frame482815 gap-16 flex-row items-start w-full opacity-100 p-0 flex">
        <div className="frame482781 gap-2 flex-col w-[620px] items-start opacity-100 p-0 flex">
          <div className="frame482807 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2997 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-[#0460a9] opacity-100 p-0" />
              <div className="interactiveIcons w-3 h-3 absolute opacity-100 p-0 left-0.5 top-0.5">
                <div className="boundingBox absolute w-3 h-3 bg-[#d9d9d9] opacity-100 p-0 inset-[0%]" />
                <svg width={10} height={10} viewBox="0 0 10 10" fill="none" xmlns="http://www.w3.org/2000/svg">
                  <path d="M4.4375 9.5V2.65156L1.2875 5.80156L0.5 5L5 0.5L9.5 5L8.7125 5.80156L5.5625 2.65156V9.5H4.4375Z" fill="white" />
                </svg>
              </div>
            </div>
            <span className="virgoliniIEtAlEurJNuclMedMolImaging201845347195 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[596px] flex-1 min-w-0">Virgolini I, et al. Eur J Nucl Med Mol Imaging. 2018;45(3):471–95.</span>
          </div>
          <div className="frame482808 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">2</span>
            </div>
            <span className="lUTATHERALutetium177LuOxodotreotideSmPCAvailableFromHttpswwwemaeuropaeuendocumentsproductInformationlutatheraEparProductInformationenpdfAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[596px] flex-1 min-w-0">LUTATHERA® (lutetium [177Lu] oxodotreotide) SmPC. Available from: <span className="text-[#0460a9] underline">https://www.ema.europa.eu/en/documents/product-information/lutathera-epar-product-information_en.pdf. Accessed May 2021.</span></span>
          </div>
          <div className="component34 w-6 h-[26px] absolute opacity-100 p-0 left-1 top-2">
            <div className="rectangle4536 absolute w-[17.48px] h-[4.26px] bg-[#d9d9d9] opacity-100 p-0 left-[20%] right-[7.18%] top-[64.62%] bottom-[19%]" />
            <div className="rectangle4533 absolute w-[3.07px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[7.19%] right-[80%] top-[42.69%] bottom-[42.4%]" />
            <div className="rectangle4534 absolute w-[20.25px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[13.44%] right-[2.19%] top-[49.12%] bottom-[35.97%]" />
            <div className="rectangle4535 absolute w-[19.13px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[14.69%] right-[5.63%] top-[53.8%] bottom-[31.29%]" />
            <div className="rectangle4537 absolute w-[12.52px] h-[1.6px] bg-[#d9d9d9] opacity-100 p-0 left-[33.44%] right-[14.38%] top-[80.99%] bottom-[12.87%]" />
            <div className="rectangle4538 absolute w-[10.95px] h-[2.81px] bg-[#d9d9d9] opacity-100 p-0 left-[37.81%] right-[16.57%] top-[85.09%] bottom-[4.09%]" />
            <div className="rectangle4539 absolute w-[3.9px] h-[12.92px] bg-[#d9d9d9] opacity-100 p-0 left-[32.81%] right-[50.94%] top-[6.14%] bottom-[44.15%]" />
            <div className="rectangle4540 absolute w-[8.77px] h-[5.63px] bg-[#d9d9d9] opacity-100 p-0 left-[43.44%] right-[20.01%] top-[30.99%] bottom-[47.37%]" />
            <div className="rectangle4541 absolute w-[5.25px] h-[3.95px] bg-[#d9d9d9] opacity-100 p-0 left-[71.56%] right-[6.56%] top-[37.43%] bottom-[47.37%]" />
            <img src="/images/image202.png" onerror="this.src='http://svgur.com/i/x4x.svg'" className="image202 absolute h-[26px] w-6 opacity-100 object-cover p-0 inset-[0%]" />
          </div>
          <div className="frame482809 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">3</span>
            </div>
            <span className="httpswwwwhointmedicinesareasprioritymedicinesCh612Osteopdf font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[596px] flex-1 min-w-0">https://www.who.int/medicines/areas/priority_medicines/Ch6_12Osteo.pdf</span>
          </div>
          <div className="frame482810 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2999 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-[#023054] opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-white text-center tracking-[0px] w-4 h-4">4</span>
            </div>
            <span ItemNumber="undefined" className="sNMMI2018PeptideReceptorRadionuclideTherapyPRRTFactSheetAvailableFromHttpswwwsnmmiorgAboutSNMMIContentaspxAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[596px] flex-1 min-w-0">SNMMI (2018). Peptide Receptor Radionuclide Therapy (PRRT) Fact Sheet. Available from:<span className="text-[#0460a9] underline"> https://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=29883. Accessed May 2021.</span></span>
          </div>
          <div className="frame482811 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">5</span>
            </div>
            <span className="trattnigSScottiCLaurentDJurasVHackerSColeBPasaLLehovecRSzomolanyiPRaithelESaxerFPraestgaardJLaGambaFJimenezJLRamosDSRoubenoffRSchiekerM2021POS0277ANABOLICEFFECTOFLNA043ANOVELDISEASEMODIFYINGOSTEOARTHRITISDRUGCANDIDATERESULTSFROMANIMAGINGBASEDPROOFOFCONCEPTTRIALINPATIENTSWITHFOCALARTICULARCARTILAGELESIONSBMJJournalsViewed4June2021Httpsardbmjcomcontent80Suppl13632 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[596px] flex-1 min-w-0">Trattnig, S, Scotti, C, Laurent, D, Juras, V, Hacker, S, Cole, B, Pasa, L, Lehovec, R, Szomolanyi, P, Raithel, E, Saxer, F, Praestgaard, J, La Gamba, F, Jiménez, J L, Ramos, D S, Roubenoff, R, Schieker M 2021, POS0277 ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS, BMJ Journals, viewed 4 June 2021, <https: 80 ard.bmj.com content Suppl_1 363.2>.</https:></span>
          </div>
        </div>
        <div className="frame482782 gap-2 flex-col w-[620px] items-start opacity-100 p-0 flex">
          <div className="frame482807 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">6</span>
            </div>
            <span className="virgoliniIEtAlEurJNuclMedMolImaging201845347195 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[596px] flex-1 min-w-0">Virgolini I, et al. Eur J Nucl Med Mol Imaging. 2018;45(3):471–95.</span>
          </div>
          <div className="frame482808 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">7</span>
            </div>
            <span className="lUTATHERALutetium177LuOxodotreotideSmPCAvailableFromHttpswwwemaeuropaeuendocumentsproductInformationlutatheraEparProductInformationenpdfAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[596px] flex-1 min-w-0">LUTATHERA® (lutetium [177Lu] oxodotreotide) SmPC. Available from: <span className="text-[#0460a9] underline">https://www.ema.europa.eu/en/documents/product-information/lutathera-epar-product-information_en.pdf. Accessed May 2021.</span></span>
          </div>
          <div className="frame482809 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">8</span>
            </div>
            <span className="httpswwwwhointmedicinesareasprioritymedicinesCh612Osteopdf font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[596px] flex-1 min-w-0">https://www.who.int/medicines/areas/priority_medicines/Ch6_12Osteo.pdf</span>
          </div>
          <div className="frame482810 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">9</span>
            </div>
            <span ItemNumber="undefined" className="sNMMI2018PeptideReceptorRadionuclideTherapyPRRTFactSheetAvailableFromHttpswwwsnmmiorgAboutSNMMIContentaspxAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[596px] flex-1 min-w-0">SNMMI (2018). Peptide Receptor Radionuclide Therapy (PRRT) Fact Sheet. Available from:<span className="text-[#0460a9] underline"> https://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=29883. Accessed May 2021.</span></span>
          </div>
          <div className="frame482811 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">10</span>
            </div>
            <span className="trattnigSScottiCLaurentDJurasVHackerSColeBPasaLLehovecRSzomolanyiPRaithelESaxerFPraestgaardJLaGambaFJimenezJLRamosDSRoubenoffRSchiekerM2021POS0277ANABOLICEFFECTOFLNA043ANOVELDISEASEMODIFYINGOSTEOARTHRITISDRUGCANDIDATERESULTSFROMANIMAGINGBASEDPROOFOFCONCEPTTRIALINPATIENTSWITHFOCALARTICULARCARTILAGELESIONSBMJJournalsViewed4June2021Httpsardbmjcomcontent80Suppl13632 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[596px] flex-1 min-w-0">Trattnig, S, Scotti, C, Laurent, D, Juras, V, Hacker, S, Cole, B, Pasa, L, Lehovec, R, Szomolanyi, P, Raithel, E, Saxer, F, Praestgaard, J, La Gamba, F, Jiménez, J L, Ramos, D S, Roubenoff, R, Schieker M 2021, POS0277 ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS, BMJ Journals, viewed 4 June 2021, <https: 80 ard.bmj.com content Suppl_1 363.2>.</https:></span>
          </div>
        </div>
      </div>
    </div>
  </>}
  {(size == "S") && <>
    <div className="c31ReferencesLegalInfo gap-12 absolute flex-col w-[375px] items-start bg-white opacity-100 pt-10 pb-16 px-4 left-[4205px] top-4 flex">
      <div className="sectionHeading gap-[-1px] flex-col w-[359px] items-start opacity-100 p-0 flex">
        <div className="frame1199 gap-2 flex-row items-start border opacity-100 px-[9px] py-[5px] border-black flex">
          <span className="sectionHeading font-['Volta_Modern_Display'] text-[17px] font-medium text-black text-left tracking-[0px]">References</span>
        </div>
        <div className="1pxDivider w-full h-px relative overflow-hidden bg-[#212121] opacity-100 p-0" />
      </div>
      <div className="frame482815 gap-2 flex-col items-start w-full opacity-100 p-0 flex">
        <div className="frame482781 gap-2 flex-col items-start w-full opacity-100 p-0 flex">
          <div className="frame482807 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2997 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-[#0460a9] opacity-100 p-0" />
              <div className="interactiveIcons w-3 h-3 absolute opacity-100 p-0 left-0.5 top-0.5">
                <div className="boundingBox absolute w-3 h-3 bg-[#d9d9d9] opacity-100 p-0 inset-[0%]" />
                <svg width={10} height={10} viewBox="0 0 10 10" fill="none" xmlns="http://www.w3.org/2000/svg">
                  <path d="M4.4375 9.5V2.65156L1.2875 5.80156L0.5 5L5 0.5L9.5 5L8.7125 5.80156L5.5625 2.65156V9.5H4.4375Z" fill="white" />
                </svg>
              </div>
            </div>
            <span className="virgoliniIEtAlEurJNuclMedMolImaging201845347195 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[319px] flex-1 min-w-0">Virgolini I, et al. Eur J Nucl Med Mol Imaging. 2018;45(3):471–95.</span>
          </div>
          <div className="frame482808 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">2</span>
            </div>
            <span className="lUTATHERALutetium177LuOxodotreotideSmPCAvailableFromHttpswwwemaeuropaeuendocumentsproductInformationlutatheraEparProductInformationenpdfAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[319px] flex-1 min-w-0">LUTATHERA® (lutetium [177Lu] oxodotreotide) SmPC. Available from: <span className="text-[#0460a9] underline">https://www.ema.europa.eu/en/documents/product-information/lutathera-epar-product-information_en.pdf. Accessed May 2021.</span></span>
          </div>
          <div className="component34 w-6 h-[26px] absolute opacity-100 p-0 left-1 top-2">
            <div className="rectangle4536 absolute w-[17.48px] h-[4.26px] bg-[#d9d9d9] opacity-100 p-0 left-[20%] right-[7.18%] top-[64.62%] bottom-[19%]" />
            <div className="rectangle4533 absolute w-[3.07px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[7.19%] right-[80%] top-[42.69%] bottom-[42.4%]" />
            <div className="rectangle4534 absolute w-[20.25px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[13.44%] right-[2.19%] top-[49.12%] bottom-[35.97%]" />
            <div className="rectangle4535 absolute w-[19.13px] h-[3.88px] bg-[#d9d9d9] opacity-100 p-0 left-[14.69%] right-[5.63%] top-[53.8%] bottom-[31.29%]" />
            <div className="rectangle4537 absolute w-[12.52px] h-[1.6px] bg-[#d9d9d9] opacity-100 p-0 left-[33.44%] right-[14.38%] top-[80.99%] bottom-[12.87%]" />
            <div className="rectangle4538 absolute w-[10.95px] h-[2.81px] bg-[#d9d9d9] opacity-100 p-0 left-[37.81%] right-[16.57%] top-[85.09%] bottom-[4.09%]" />
            <div className="rectangle4539 absolute w-[3.9px] h-[12.92px] bg-[#d9d9d9] opacity-100 p-0 left-[32.81%] right-[50.94%] top-[6.14%] bottom-[44.15%]" />
            <div className="rectangle4540 absolute w-[8.77px] h-[5.63px] bg-[#d9d9d9] opacity-100 p-0 left-[43.44%] right-[20.01%] top-[30.99%] bottom-[47.37%]" />
            <div className="rectangle4541 absolute w-[5.25px] h-[3.95px] bg-[#d9d9d9] opacity-100 p-0 left-[71.56%] right-[6.56%] top-[37.43%] bottom-[47.37%]" />
            <img src="/images/image202.png" onerror="this.src='http://svgur.com/i/x4x.svg'" className="image202 absolute h-[26px] w-6 opacity-100 object-cover p-0 inset-[0%]" />
          </div>
          <div className="frame482809 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">3</span>
            </div>
            <span className="httpswwwwhointmedicinesareasprioritymedicinesCh612Osteopdf font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[319px] flex-1 min-w-0">https://www.who.int/medicines/areas/priority_medicines/Ch6_12Osteo.pdf</span>
          </div>
          <div className="frame482810 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2999 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-[#023054] opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-white text-center tracking-[0px] w-4 h-4">4</span>
            </div>
            <span ItemNumber="undefined" className="sNMMI2018PeptideReceptorRadionuclideTherapyPRRTFactSheetAvailableFromHttpswwwsnmmiorgAboutSNMMIContentaspxAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[319px] flex-1 min-w-0">SNMMI (2018). Peptide Receptor Radionuclide Therapy (PRRT) Fact Sheet. Available from:<span className="text-[#0460a9] underline"> https://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=29883. Accessed May 2021.</span></span>
          </div>
          <div className="frame482811 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">5</span>
            </div>
            <span className="trattnigSScottiCLaurentDJurasVHackerSColeBPasaLLehovecRSzomolanyiPRaithelESaxerFPraestgaardJLaGambaFJimenezJLRamosDSRoubenoffRSchiekerM2021POS0277ANABOLICEFFECTOFLNA043ANOVELDISEASEMODIFYINGOSTEOARTHRITISDRUGCANDIDATERESULTSFROMANIMAGINGBASEDPROOFOFCONCEPTTRIALINPATIENTSWITHFOCALARTICULARCARTILAGELESIONSBMJJournalsViewed4June2021Httpsardbmjcomcontent80Suppl13632 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[319px] flex-1 min-w-0">Trattnig, S, Scotti, C, Laurent, D, Juras, V, Hacker, S, Cole, B, Pasa, L, Lehovec, R, Szomolanyi, P, Raithel, E, Saxer, F, Praestgaard, J, La Gamba, F, Jiménez, J L, Ramos, D S, Roubenoff, R, Schieker M 2021, POS0277 ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS, BMJ Journals, viewed 4 June 2021, <https: 80 ard.bmj.com content Suppl_1 363.2>.</https:></span>
          </div>
        </div>
        <div className="frame482782 gap-2 flex-col items-start w-full opacity-100 p-0 flex">
          <div className="frame482807 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">6</span>
            </div>
            <span className="virgoliniIEtAlEurJNuclMedMolImaging201845347195 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[319px] flex-1 min-w-0">Virgolini I, et al. Eur J Nucl Med Mol Imaging. 2018;45(3):471–95.</span>
          </div>
          <div className="frame482808 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">7</span>
            </div>
            <span className="lUTATHERALutetium177LuOxodotreotideSmPCAvailableFromHttpswwwemaeuropaeuendocumentsproductInformationlutatheraEparProductInformationenpdfAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[319px] flex-1 min-w-0">LUTATHERA® (lutetium [177Lu] oxodotreotide) SmPC. Available from: <span className="text-[#0460a9] underline">https://www.ema.europa.eu/en/documents/product-information/lutathera-epar-product-information_en.pdf. Accessed May 2021.</span></span>
          </div>
          <div className="frame482809 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">8</span>
            </div>
            <span className="httpswwwwhointmedicinesareasprioritymedicinesCh612Osteopdf font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[319px] flex-1 min-w-0">https://www.who.int/medicines/areas/priority_medicines/Ch6_12Osteo.pdf</span>
          </div>
          <div className="frame482810 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">9</span>
            </div>
            <span ItemNumber="undefined" className="sNMMI2018PeptideReceptorRadionuclideTherapyPRRTFactSheetAvailableFromHttpswwwsnmmiorgAboutSNMMIContentaspxAccessedMay2021 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[319px] flex-1 min-w-0">SNMMI (2018). Peptide Receptor Radionuclide Therapy (PRRT) Fact Sheet. Available from:<span className="text-[#0460a9] underline"> https://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=29883. Accessed May 2021.</span></span>
          </div>
          <div className="frame482811 gap-2 flex-row items-start w-full opacity-100 p-0 flex">
            <div className="group2998 w-4 h-4 relative p-0">
              <div className="rectangle5630 w-4 h-4 relative bg-neutral-100 opacity-100 p-0" />
              <span className="copy font-['Volta_Modern_Display'] text-[10px] font-semibold text-[#2877b6] text-center tracking-[0px] w-4 h-4">10</span>
            </div>
            <span className="trattnigSScottiCLaurentDJurasVHackerSColeBPasaLLehovecRSzomolanyiPRaithelESaxerFPraestgaardJLaGambaFJimenezJLRamosDSRoubenoffRSchiekerM2021POS0277ANABOLICEFFECTOFLNA043ANOVELDISEASEMODIFYINGOSTEOARTHRITISDRUGCANDIDATERESULTSFROMANIMAGINGBASEDPROOFOFCONCEPTTRIALINPATIENTSWITHFOCALARTICULARCARTILAGELESIONSBMJJournalsViewed4June2021Httpsardbmjcomcontent80Suppl13632 font-['Volta_Modern_Display'] text-[11px] font-medium text-[#212121] text-left tracking-[0px] w-[319px] flex-1 min-w-0">Trattnig, S, Scotti, C, Laurent, D, Juras, V, Hacker, S, Cole, B, Pasa, L, Lehovec, R, Szomolanyi, P, Raithel, E, Saxer, F, Praestgaard, J, La Gamba, F, Jiménez, J L, Ramos, D S, Roubenoff, R, Schieker M 2021, POS0277 ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS, BMJ Journals, viewed 4 June 2021, <https: 80 ard.bmj.com content Suppl_1 363.2>.</https:></span>
          </div>
        </div>
      </div>
    </div>
  </>}
</>
  );
}